Gapping down
In reaction to disappointing earnings/guidance: ADBE -21.1% (also downgraded to Neutral from Buy at UBS, downgraded to Hold from Buy at ThinkEquity, downgraded to Mkt Perform at FBR Capital, downgraded to Neutral from Outperform at Robert W. Baird, downgraded to Hold from Buy at ISI Group, downgraded to Neutral from Outperform at Credit Suisse), PMCS -7.6%, JEF -6.0%, DRI -2.2%, EBAY -1.8% (said it expects its third quarter 2010 results to be near the high end of the guidance provided on July 21).
Select financial related names showing weakness: HIG -4.2%, STD -2.0% (downgraded to Neutral from Outperform at Credit Suisse), RBS -1.8%, HBC -1.3% (reports out overnight that the CEO has threatened to quit if not appointed Chairman), GS -1.1%, PRU -1.0%.
Other news: VICL -35.2% (Sanofi-Aventis announced that the Phase III TAMARIS trial evaluating the investigational angiogenic therapy NV1FGF did not meet its primary endpoint), FUR -8.7% (prices offering of 5 mln common shares of beneficial interest at a public offering price of $12.25 per share), SFI -8.0% (continued weakness following yesterdays drop in reports the co is preparing for bankruptcy filing), SQNM -7.8% (files $150 mln mixed securities shelf offering ), ARE -4.2% (commences underwritten public offering of 4 mln shares of common stock), ENTG -4.0% (weakness attributed to tier 1 firm downgrade), ELN -3.8% (BIIB's partner for Tysabri), BIIB -3.4% (makes statement about U.S. FDA approval of Gilenya; expects a significant drop in net new patients on Tysabri), MKSI -2.6% (weakness attributed to tier 1 firm downgrade), AMR -2.6% (disclosed updated fuel forecast and hedging positions), MSFT -0.6% (increases quarterly dividend by 23%; board authorized up to $6 bln in incremental commercial paper and longer-term debt).
Analyst comments: AMTD -2.2% (downgraded to Market Perform from Outperform at Raymond James), SOHU -0.9% (downgraded to Neutral from Positive at Susquehanna).
Gapping up
In reaction to strong earnings/guidance: CDCS +6.2% (thinly traded, ticking higher), ALOG +4.4%.
M&A news: MAJC +77.3% (to be acquired by Bayside Capital Partners for $0.45 per share in cash).
Select metals/mining stocks seeing continued strength after gold made new all-time highs yesterday: NGD +2.5%, NG +2.3%, KGC +1.9%, GSS +1.8%, AUY +1.6%, EGO +1.5%, BBL +1.5%, BHP +1.4%, RTP +1.4%, SLW +1.3%, MT +1.3%, GDX +0.9%, GOLD +0.6%, GLD +0.4%.
Other news: BRT +16.5% (intends to commence tender offer to repurchase up to 2.5 mln of its shares of beneficial interest at $6.30/share), OGXI +11.4% (publishes data from randomized Phase 2 custirsen trial ), BQI +9.8% (Oilsands Quest to Pursue Sale of Non-core Assets ), SEED +9.4% (reaches worldwide agreement for Bt Gene ), SAY +8.5% (still checking), CLGX +3.4% (Cramer recommends buying the stock as a housing play - CNBC), PWER +3.3% (authorizes 10 mln share repurchase program; authorized for two years and effective immediately).
Analyst comments: VVUS +6.8% (upgraded to Buy from Hold at Canaccord Genuity).